The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehrlich, L. C.
Right arrow Articles by Chao, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehrlich, L. C.
Right arrow Articles by Chao, C. C.
The Journal of Immunology, 1998, 160: 1944-1948.
Copyright © 1998 by The American Association of Immunologists

Cytokine Regulation of Human Microglial Cell IL-8 Production1

Laura C. Ehrlich*, Shuxian Hu*,{ddagger}, Wen S. Sheng*, Richard L. Sutton{dagger},{ddagger}, Gaylan L. Rockswold{dagger},{ddagger}, Phillip K. Peterson*,{ddagger} and Chun C. Chao2,*,{ddagger}

* Neuroimmunobiology and Host Defense Laboratory, and {dagger} Neurotrauma Research Laboratory, Minneapolis Medical Research Foundation, and {ddagger} University of Minnesota Medical School, Minneapolis, MN 55404


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IL-8 involvement in neutrophil activation and chemotaxis may be important in inflammatory responses within the central nervous system, secondary to meningitis, encephalitis, and traumatic injury. The source of IL-8 within the brain during these inflammatory processes, however, is unknown. To explore the role of microglia in the production of IL-8, human fetal microglia, which are the resident macrophages of the brain, were treated with LPS and pro- and anti-inflammatory cytokines to determine their effects on IL-8 production. We found that IL-8 protein levels increased in response to LPS or IL-1ß, or to TNF-{alpha}, which also corresponded to elevated IL-8 mRNA levels by RT-PCR. Pretreatment with IL-4, IL-10, or TGF-ß1 potently inhibited the stimulatory effects of these proinflammatory agents. These findings indicate that human microglia synthesize IL-8 in response to proinflammatory stimuli, and that anti-inflammatory cytokines down-regulate the production of this chemokine. These results may have important therapeutic implications for certain central nervous system insults involving inflammation.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Acute bacterial (purulent) meningitis occurs when bacteria gain access to the subarachnoid space, usually via the nasopharynx or systemic circulation, prompting the entry of neutrophils. Although effective antibiotics are available, substantial mortality due to bacterial meningitis persists and high rates of neurologic sequelae occur in patients who survive the initial infection (1). Recent advances have shown that the inflammatory response in the brain, triggered by bacterial products such as LPS, a major cell wall component of Neisseria meningitidis (meningococcus) and Haemophilus influenzae type b (Hib), may be partially responsible for the morbidity (2).

Bacteria induce the production of cytokines by many cell types including leukocytes and endothelial cells (3) that form the vascular component of the blood-brain barrier (BBB).3 Additionally, astrocytes, which are the predominant cell type on the brain side of the BBB, and microglial cells (contributing up to 20% of the brain cells of the BBB (4)) produce a wide variety of cytokines and ß-chemokines (5, 6, 7) when activated. Cytokines appear to either play a protective role or initiate an irreversible over-reaction of the immune system ultimately leading to cell death (8). Both IL-1ß and TNF-{alpha} are produced during meningeal inflammation (9, 10, 11, 12, 13) and have been implicated in cellular damage (14, 15, 16, 17, 18). Furthermore, they have been found to initiate an inflammatory cascade (19) that includes the release of IL-8 (20, 21).

IL-8, a member of the C-X-C ({alpha}) chemokine family, has been detected in the cerebrospinal fluid (CSF) of patients with bacterial meningitis (22, 23, 24, 25, 26, 27). Although the role of IL-8 and the specific cells that produce it during meningeal inflammation are unknown, studies have shown that IL-8 is a potent chemoattractant and activator of neutrophils (21, 28). This activation may be exhibited by increased respiratory burst activity, the production of bioactive lipids, and the release of lysosomal enzymes, potentially contributing to tissue injury (29, 30). IL-8 also regulates neutrophil adhesion to endothelial cells (31), possibly mediating the large influx of these cells into the subarachnoid space that is seen in patients with bacterial meningitis (2). The release of IL-8 by cells comprising the BBB (specifically, astrocytes and microglia) may be a key component in this influx.

Aloisi et al. reported that human astrocytes synthesize IL-8 in response to IL-1ß and TNF-{alpha} (32), but the production of IL-8 by primary human microglia, which migrate to and proliferate at sites of inflammation (33), has not been shown previously. Therefore, we examined IL-8 production by microglia obtained from fetal and adult human brain tissue in response to LPS, IL-1ß, and TNF-{alpha}. We also investigated the regulatory effects of anti-inflammatory cytokines (IL-4, IL-10, and TGF-ß) on IL-8 production by microglial cells, since the regulation of IL-8 seems critical to the control of the inflammatory response in conditions such as meningitis. Finally, we tested whether LPS or proinflammatory cytokines could induce astrocytes to produce IL-8.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents

TNF-{alpha}, IL-1ß, IL-4, IL-8, IL-10, TGF-ß1, and anti-IL-8 Abs were kindly provided by R&D Systems, Inc. (Minneapolis, MN). Anti-goat horseradish peroxidase conjugate was obtained from Jackson ImmunoResearch (West Grove, PA). LPS and Tween-20 were acquired from Sigma Chemical Co. (St. Louis, MO).

Brain cell cultures

Human fetal brain tissues were obtained from 16- to 22-wk-old aborted fetuses under a protocol approved by the Human Subjects Research Committee at our institution. These cultures were prepared using a previously described technique (34). Briefly, brain tissues were dissociated after a 45-min trypsinization (0.125%) and were seeded into 75-cm2 Falcon culture flasks (Fisher Scientific, Pittsburgh, PA) in DMEM (Sigma) containing 10% heat-inactivated serum (Hyclone Laboratories, Logan, UT) and penicillin/streptomycin (Sigma). On day 10 to 12 of culture, harvested cells (microglia) were seeded into 96-well plates.

Adult brain specimen tissues (~0.01 g) were obtained from patients (with informed consent) undergoing elective or emergency neurosurgical procedures at Hennepin County Medical Center (Minneapolis, MN) and prepared following a slightly modified protocol from that used for processing fetal microglia. Following trypsinization, cells were resuspended in 35.6 ml PBS, layered over a gradient containing 9.6 ml of 100% Percoll (Sigma) and 4.8 ml of 1.25 M sucrose (Sigma), and centrifuged at 14,000 rpm for 45 min. Collected cells were washed and plated into 75-cm2 flasks. On day 14 of culture, microglia (5 x 103 cells/well) were seeded into 96-well plates. Purified fetal or adult microglia were composed of cell populations, >99% of which stained with CD68 Abs (Dako, Carpenteria, CA), a microglial cell marker, and <1% of which stained with Abs to glial fibrillary acid protein (Dako), an astrocyte marker.

Fetal astrocytes were prepared as previously described (35). More than 99% of the cells were positive for glial fibrillary acid protein. Astrocytes were seeded into 96-well plates at a density of 5 x 103 cells/well.

Monocyte-derived macrophage (MDM) cultures

Whole blood was drawn from healthy laboratory donors and diluted with sterile PBS. This mixture was added to a Ficoll-Hypaque gradient (Lymphocyte Separation Medium, Organon Teknika Corp., Durham, NC) and centrifuged at 1400 rpm for 30 min. PBMC were collected from the gradient and washed three times in PBS. The cells were then resuspended in RPMI 1640 (Sigma) with antibiotics, and monocytes were allowed to adhere to the bottom of a 24-well plate for 2 to 3 h. Nonadherent cells were washed off vigorously several times, and RPMI 1640 containing 10% FBS and antibiotics was re-added. Monocytes were allowed to differentiate into MDMs for 5 days in a 5%-CO2 environment at 37°C.

Experimental protocol

In all experiments testing IL-8 protein production, cells were washed once and treated the day after plating. Controls, which were cells incubated in medium alone, were included in all experiments. Supernatants were collected at 16 to 18 h and frozen at -20°C to be tested later by ELISA. To evaluate the effects of LPS, IL-1ß, and TNF-{alpha} on IL-8 production by microglia, cells (5 x 103 per well) were treated with LPS, IL-1ß, or TNF-{alpha} at the indicated doses. Cytokine specificity was determined by pretreating microglial cells (5 x 103 per well) with 10 µg/ml rabbit anti-human IL-1ß Ab (Genzyme, Cambridge, MA) or anti-human TNF-{alpha} Ab (R&D Systems) for 45 min followed by 16 h of stimulation with either IL-1ß (10 ng/ml) or TNF-{alpha} (20 ng/ml), respectively, and then measuring a decrease in IL-8 production in the Ab-treated wells compared with the stimulated wells alone. The effects of anti-inflammatory cytokines were tested by pretreating cells with IL-4, IL-10, or TGF-ß1 for 6 h. Then LPS, IL-1ß, or TNF-{alpha} were added alone or in combination with IL-4, IL-10, or TGF-ß1, and the cells were allowed to incubate overnight. Adult microglia, MDM, and astrocytes (all at 5 x 103 cells/well) were treated with LPS, IL-1ß, or TNF-{alpha} and compared with fetal microglial cells treated in an identical manner.

RT-PCR

Total RNA was extracted from microglia using guanidinium isothiocyanate as previously described (36). Reverse transcription of 1.5 µg of RNA was performed with 50 µM oligo(dT)12–18 followed by the addition of a reaction mixture containing 5x first strand buffer (250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 mM MgCl2), 0.1 MDTT), SuperScript II RNase H- Reverse Transcriptase (Life Technologies, Gaithersburg, MD), and 10 mM deoxynucleoside triphosphates mix (10 mM each of dATP, dGTP, dCTP, and dHP (Pharmacia Biotech, Piscataway, NJ) in a final volume of 20 µl. The mixture was incubated at 42°C for 1 h followed by termination at 95°C for 5 min. Amplification of IL-8 or glyceraldehyde-3-phosphate dehydrogenase (GADPH) cDNA (as a control) was performed with an automatic thermocycler (Stratagene, La Jolla, CA) in a reaction mixture containing 10x PCR buffer (500 mM KCl, 100 mM Tris-HCl (pH 9.0 at 25°C), and 1% Triton X-100), 25 mM MgCl2, 10 mM deoxynucleoside triphosphates mixture, 5 U of Taq DNA polymerase (Promega, Madison, WI) per µl with 0.22 µg/µl TaqStart Ab (Clontech, Palo Alto, CA), 25 µM primer (sense and antisense), cDNA, and H2O. Amplification was set at 94°C for 45 s, 65°C for 45 s, and 72°C for 90 s followed by a 10-min extension at 72°C.

The IL-8 PCR product (289 bp) was amplified for 17 to 19 cycles and the GADPH (600 bp) for 22 cycles. Both PCR products were viewed under UV light after 2% agarose gel electrophoresis and staining in ethidium bromide. The IL-8 primer sets (Clontech) were 5'-ATG ACT TCC AAG CTG GCC GTG GCT-3' (sense) and 5'-TCT CAG CCC TCT TCA AAA ACT TCT C-3' (antisense). The GADPH primer sets (Stratagene) were 5'-ACC ACA GTC CAT GCC ATC AC-3' (sense) and 5'-TCC ACC ACC CTG TTG CTG TA-3' (antisense).

ELISA

IL-8 protein was detected by an ELISA developed in our laboratory. Briefly, 96-well culture plates were coated with 0.1 µg/ml mouse anti-human IL-8 mAb and stored overnight at 4°C. The following day, the plates were washed with 0.05% PBS/Tween-20 and nonspecific binding was blocked by treatment with 1% BSA for 1 h at 37°C. After washing, a standard series of diluted human rIL-8 was added to each plate along with supernatant samples and incubated for 2 h at 37°C. Next, goat anti-human IL-8 Ab (2 µg/ml) was added for 1.5 h at 37°C followed by anti-goat IgG horseradish peroxidase conjugate (1:20,000 in PBS) for 1 h. After extensive washing with PBS/Tween-20, K-Blue Substrate (Neogen Corporation, Lexington, KY) was added for 10 to 20 min at room temperature for color development, and then the development was stopped by the addition of 100 µl of 1 M H2SO4. OD was read at 450 nm and compared with standard values for quantification. The sensitivity of this assay is 10 pg/ml, and is specific for IL-8.

Statistical analysis

When appropriate, data were analyzed for comparison of multiple means using ANOVA followed by Scheffe’s F test. Statistical significance was determined at the level of 95% confidence.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Initially, IL-8 production by human fetal microglial cells was tested at 8, 24, and 48 h following LPS (1 µg/ml) stimulation. In the culture supernatants, IL-8 increased over time with maximal production observed at 48 h in both the control (67 ± 21 ng/ml) and LPS-stimulated (360 ± 10 ng/ml) cultures. IL-8 production was minimal at 8 h in the control cultures (4 ± 1 ng/ml) but was markedly increased in the LPS-treated cultures (150 ± 2 ng/ml). After 24 h, LPS-stimulated microglia released more IL-8 (288 ± 10 ng/ml) with the control values remaining low (13 ± 1 ng/ml). Based on these findings and on subsequent experiments at 16 h showing similar IL-8 production, a time point of 16 h poststimulation was selected for the remaining experiments.

After treatment with varying doses of LPS, IL-1ß, and TNF-{alpha}, fetal microglial cell culture supernatants were tested by ELISA for IL-8 protein (Fig. 1Go). LPS and IL-1ß stimulated IL-8 in a dose-dependent manner (ED50 = 20 pg and 2 ng, respectively) with a maximal production of 180 ± 20 ng/ml and 161 ± 15 ng/ml, respectively. TNF-{alpha} also increased IL-8 production over the control level (40 ± 1 ng/ml compared with 7 ± 1 ng/ml; ED50 = 200 pg/ml) but the maximal stimulation of IL-8 by TNF-{alpha} was less than that observed with LPS and IL-1ß (Fig. 1Go). All data points in Figure 1Go were greater than control values (p < 0.05) with the exception of the 0.01 and 0.1 ng/ml IL-1ß-stimulated and 0.01 ng/ml LPS-stimulated treatments. IL-8 release induced by IL-1ß and TNF-{alpha} was cytokine specific, as mAbs against each cytokine inhibited IL-8 production by 75 ± 6% and 92 ± 9%, respectively (data from two separate experiments). These proinflammatory stimuli also increased IL-8 mRNA levels in human fetal microglia (Fig. 2Go). A low level of constitutive expression of IL-8 mRNA was seen in the control cells, but only at higher amplification.



View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 1. Dose-response effects of LPS, IL-1ß, and TNF-{alpha} on human fetal microglial cell IL-8 production. Microglial cells were treated with the indicated concentrations of proinflammatory mediators for 16 h, and supernatants were collected and assayed for IL-8. Data (mean ± SEM) are representative of three separate experiments with microglia from different brain tissue specimens.

 


View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 2. Effects of LPS, IL-1ß, and TNF-{alpha} on human fetal microglial cell IL-8 mRNA expression. Microglia were treated with 1 µg/ml LPS, 10 ng/ml IL-1ß, and 20 ng/ml TNF-{alpha} for 6 h before RNA extraction. The RT-PCR product shown was amplified for 17 cycles. Lane M shows a 100 bp marker, lane C shows medium-only treated cells, and lane H2O contains no cDNA for an internal control. Results are representative of three separate experiments.

 
Next, we studied the effect of anti-inflammatory cytokines on fetal microglial cell IL-8 production. The production of IL-8 in response to all three proinflammatory stimuli (i.e., LPS, IL-1ß, and TNF-{alpha}) was inhibited by IL-4, IL-10, and TGF-ß1 at levels of 59% to 86% inhibition at maximal doses (Fig. 3Go, A–C). These anti-inflammatory cytokines were most effective in decreasing IL-1ß- and TNF-{alpha}-stimulated IL-8 production. IL-4, IL-10, or TGF-ß1 alone had a minimal effect on constitutive expression relative to the amount of control production of IL-8. All the data in Figure 3Go, A–C, were different (p < 0.05) than the values obtained with the stimulus alone (i.e., LPS, IL-1ß, or TNF-{alpha}) with the exception of the IL-4 (0.3 ng/ml)/TNF-{alpha}-stimulated and the IL-10 (0.1 ng/ml)/IL-1ß-stimulated points. When using RT-PCR at the transcriptional level, microglial cells treated with LPS, IL-1ß, and TNF-{alpha} exhibited smaller bands when pretreated with IL-4 or IL-10 overnight (Fig. 4Go). TGF-ß1 appeared to have no effect on LPS- and IL-1ß-induced IL-8 mRNA expression, but potentially decreased IL-8 mRNA expression in the TNF-{alpha}-treated cells. These observed decreases may have been due to differing transcription rates and/or altered mRNA message stability, neither of which were analyzed in the present study.



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 3. Cytokine regulation of IL-8 production. Human fetal microglia cells were pretreated with the indicated concentrations of IL-4 (A), IL-10 (B), or TGF-ß1 (C) for 6 h and then stimulated for 16 h with LPS (1 µg/ml), IL-1ß (10 ng/ml), or TNF-{alpha} (20 ng/ml). Data, expressed as percent inhibition of cytokine-stimulated IL-8 production, are representative of five separate experiments.

 


View larger version (50K):
[in this window]
[in a new window]
 
FIGURE 4. Effects of IL-4, IL-10, and TGF-ß1 on IL-8 mRNA expression. Cells were pretreated with IL-4 (30 ng/ml), IL-10 (10 ng/ml), or TGF-ß1 (10 ng/ml) for 16 h and then stimulated with LPS (10 ng/ml), IL-1ß (10 ng/ml), or TNF-{alpha} (20 ng/ml) for 4 h. Controls were treated either with media (-) or with LPS, IL-1ß, or TNF-{alpha} alone (+). GADPH primer was used for an internal control. The IL-8 PCR product was amplified for 17 to 19 cycles, while the GADPH product was amplified for 22 cycles.

 
Finally, the ability of fetal microglia to produce IL-8 was compared both with that of microglia isolated from adult brain tissue and with MDM, as well as with fetal astrocytes. IL-8 production by microglia from fetal and adult brain tissue was comparable with IL-8 produced by MDM (Table IGo). Compared with control values at 16 h, LPS and IL-1ß increased IL-8 production (p <= 0.05), but the TNF-{alpha}-stimulated increase was not significant. In sharp contrast to the mononuclear phagocytes, astrocytes produced no IL-8 in response to LPS. However, IL-1ß was a potent stimulus of IL-8 production by astrocytes (80 ± 15 ng/ml), and TNF-{alpha} elicited relatively low amounts of IL-8 (5 ± 1 ng/ml) (Table IGo).


View this table:
[in this window]
[in a new window]
 
Table I. IL-8 production by different cell typesa

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The results of this study indicate that both human fetal and adult microglial cells (as well as MDM) produce IL-8 in response to LPS, IL-1ß, and TNF-{alpha}, two cytokines that play a key role in the initiation of an inflammatory response. This production appears to be dose dependent in fetal microglia and is inhibited by the anti-inflammatory cytokines IL-4, IL-10, and TGF-ß.

The role of chemokines such as IL-8 in CNS diseases is not understood completely. Chemokines attract specific cell types (such as T lymphocytes and monocytes) to the CNS, but how they help these cells cross the BBB has not been fully delineated. However, chemokines (including IL-8, macrophage inflammatory protein (MIP)-1ß, MIP-1{alpha}, monocyte chemoattractant protein (MCP)-1, RANTES, and IFN-inducible protein-10) up-regulate cell adhesion molecules, potentially aiding leukocyte trafficking across the BBB (37). Chemokines are regulated by various cytokines, and a complete understanding of these interacting pathways could give important insights into disease progression (38).

IL-8 synthesis by human microglia adds further support to the hypothesis that IL-8 is involved in the pathogenesis of acute bacterial meningitis and other CNS diseases including Alzheimer’s disease (39, 40). The production of IL-8 during inflammation is fairly well established (41, 42). Interestingly, the release of IL-8 and other proinflammatory cytokines occurs before neutrophil influx during meningitis (3, 12), suggesting that initial contact with LPS or other bacterial products induces cells such as microglia and endothelial cells to synthesize IL-8. Our results also show that LPS does not stimulate astrocytes to make IL-8; however, IL-1ß is a potent stimulus for astrocyte IL-8 production. Since LPS has been shown to cause microglial cells to release IL-1ß (17), the potential exists for astrocytes to synthesize IL-8 in response to this microglial source of IL-1ß. Human microglia stimulated with LPS, IL-1ß, and TNF-{alpha} produce MIP-1{alpha}, MIP-1ß, and MCP-1 (7), which also may contribute to CNS pathogenesis.

IL-8 has been shown to induce neutrophil recruitment to the brain parenchyma in vivo (43, 44). Once neutrophils have crossed the BBB, IL-8 induces degranulation of neutrophils that are releasing chemoattractants for T lymphocytes (45) and primes neutrophils for superoxide production (46) along with other potentially neurotoxic molecules. Thus, while the influx of neutrophils has been shown to reduce the numbers of bacteria in experimental models of bacterial meningitis, an excess of activated neutrophils may have a detrimental effect. Regulation of IL-8 chemotactic and activating activity may be beneficial in reducing the potentially negative effects of neutrophil influx. However, other chemokines, including MIP-2 and IFN-inducible protein-10, also induce neutrophil recruitment to the CNS (43) complicating the milieu of factors to be regulated. Monocytic chemoattraction into the CNS by chemokines such as MCP-1, MIP-1{alpha}, MIP-1ß, and RANTES may also contribute to cellular damage (38, 43), and most of these chemokines have been found at elevated levels in the CSF of patients with bacterial meningitis (47).

Additionally, these results show that while LPS, IL-1ß, and TNF-{alpha} up-regulate the production of IL-8 by microglial cells at a transcriptional level, the anti-inflammatory cytokines IL-4 and IL-10 may inhibit IL-8 synthesis at that same level. TGF-ß1 also decreased IL-8 production by microglial cells in response to these proinflammatory mediators but appeared not to function at the level of transcription. These findings correspond with previous research performed on endothelial cells (22, 48), neutrophils (49), and in vivo models (50); however, our results could be due to altered message stability or differing rates of transcription. Additionally, IL-10 and TGF-ß1 have been found in the CSF of patients with bacterial meningitis (51, 52, 53), suggesting these cytokines could modulate IL-8 production in vivo.

In conclusion, the interactions between microglia, IL-8, and neutrophils appear important in understanding the pathogenesis of acute bacterial meningitis and other CNS insults involving inflammation including brain trauma (54, 55). Further studies to delineate the mechanisms through which LPS, IL-1ß, and TNF-{alpha} induce IL-8 and the production of other chemokines and to determine whether microglia and astrocytes produce IL-8 in vivo (leading to a migration of neutrophils across the BBB or to further activation of neutrophils once they cross the BBB) would contribute to greater knowledge and potential therapies for brain insults involving inflammation.


    Footnotes
 
1 This study was financed in part by United States Public Health Service Grants DA-09924 and DA-04381 and a grant from the Alzheimer’s Association. Back

2 Address correspondence and reprint requests to Dr. Chun C. Chao, Minneapolis Medical Research Foundation, 914 South 8th St., D-3, Minneapolis, MN 55404. E-mail address: Back

3 Abbreviations used in this paper: BBB, blood-brain barrier; CNS, central nervous system; MDM, monocyte-derived macrophage; CSF, cerebrospinal fluid; GADPH, glyceraldehyde-3-phosphate dehydrogenase; MIP, macrophage inflammatory protein; MCP-1, monocyte chemoattractant protein-1. Back

Received for publication June 26, 1997. Accepted for publication October 31, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Täuber, M. G., Y. S. Kim, S. L. Leib. 1997. Neuronal injury in meningitis. J. S. Remington, and P. K. Peterson, eds. In Defense of the Brain: New Concepts in Pathogenesis, Treatment, and Prevention of CNS Infections 124. Blackwell Science, Boston.
  2. Tunkel, A. R., W. M. Scheld. 1993. Pathogenesis and pathophysiology of bacterial meningitis. Annu. Rev. Med. 44:103.[Medline]
  3. Van Furth, A. M., J. J. Roord, R. Van Furth. 1996. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect. Immun. 64:4883.[Medline]
  4. Streit, W. J.. 1995. Microglia cells. H. Kettenmann, and B. R. Ransom, eds. Neuroglia 85. Oxford University Press, New York.
  5. Benveniste, E. N.. 1995. Cytokine production. H. Kettenmann, and B. R. Ransom, eds. Neuroglia 700. Oxford University Press, New York.
  6. Peterson, P. K., G. Gekker, S. Hu, C. C. Chao. 1997. Microglia: a "double-edged sword.". J. S. Remington, and P. K. Peterson, eds. In Defense of the Brain: New Concepts in Pathogenesis, Treatment and Prevention of CNS Infections 31. Blackwell Science, Boston.
  7. Peterson, P. K., S. Hu, J. Salak-Johnson, T. W. Molitor, C. C. Chao. 1997. Differential production of and migratory response to ß chemokines by human microglia and astrocytes. J. Infect. Dis. 175:478.[Medline]
  8. Sàez-Llorens, X., Jr G. H. McCracken. 1997. Contribution of cytokines to meningeal inflammation in bacterial meningitis. J. S. Remington, and P. K. Peterson, eds. In Defense of the Brain: New Concepts in Pathogenesis, Treatment and Prevention of CNS Infections 107. Blackwell Science, Boston.
  9. Jr McCracken, G. H, M. M. Mustafa, O. Ramilo, K. D. Olsen, R. C. Risser. 1989. Cerebrospinal fluid interleukin 1 beta and tumor necrosis factor concentrations and outcome from neonatal Gram-negative enteric bacillary meningitis. Pediatr. Infect. Dis. J. 8:155.[Medline]
  10. Mustafa, M. M., M. H. Lebel, O. Ramilo, K. D. Olsen, J. S. Reisch, B. Beutler, Jr G. H. McCracken. 1989. Correlation of interleukin-1ß and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115:208.[Medline]
  11. Mustafa, M. M., O. Ramilo, K. D. Olsen, P. S. Franklin, E. J. Hansen, B. Beutler, Jr G. H. McCracken. 1989. Tumor necrosis factor in mediating experimental Haemophilus influenzae type b meningitis. J. Clin. Invest. 84:1253.
  12. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Kierulf, T. Espevik. 1989. Local production of tumor necrosis factor {alpha}, interleukin 1, and interleukin 6 in meningococcal meningitis: relation to the inflammatory response. J. Exp. Med. 170:1859.[Abstract/Free Full Text]
  13. Glimåker, M., P. Kragsbjerg, M. Forsgren, P. Olcén. 1993. Tumor necrosis factor-{alpha} (TNF{alpha}) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF{alpha} indicate bacterial meningitis. J. Infect. Dis. 167:882.[Medline]
  14. Hu, S., W. S. Sheng, P. K. Peterson, C. C. Chao. 1995. Cytokine modulation of murine microglial cell superoxide production. Glia 13:45.[Medline]
  15. Chao, C. C., S. Hu. 1994. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16:172.[Medline]
  16. Chao, C. C., S. Hu, L. Ehrlich, P. K. Peterson. 1995. Interleukin-1 and tumor necrosis factor-{alpha} synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9:355.[Medline]
  17. Chao, C. C., S. Hu, P. K. Peterson. 1995. Glia, cytokines, and neurotoxicity. Crit. Rev. Neurobiol. 9:189.[Medline]
  18. Chao, C. C., S. Hu, P. K. Peterson. 1996. Glia: the not so innocent bystanders. J. Neurovirol. 2:234.[Medline]
  19. Ramilo, O., X. Sàez-Llorens, J. Mertsola, H. Jafarai, K. D. Olsen, E. J. Hansen, M. Yoshinaga, S. Ohkawara, H. Nariuchi, and G. H. McCracken, Jr. Tumor necrosis factor and interleukin-1 initiate meningeal inflammation. J. Exp. Med.172:497.
  20. Matsushima, K., E. T. Baldwin, N. Mukaida. 1992. Interleukin-8: novel leukocyte recruitment and activating cytokine. Chem. Immunol. 51:236.[Medline]
  21. Baggiolini, M., A. Walz, S. L. Kunkel. 1989. Neutrophil activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045.
  22. Spanous, K.-S., D. Nadal, H.-W. Pfister, J. Seebach, U. Widmer, K. Frei, S. Gloor, A. Fontana. 1997. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158:1956.[Abstract]
  23. Lopez-Cortes, L. F., M. Cruz-Ruiz, J. Gomez-Mateos, P. Vician-Fernanadez, F. J. Martinez-Marcos, J. Pachon. 1995. Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. J. Infect. Dis. 172:581.[Medline]
  24. Mastroianni, C. M., F. Paoletti, R. M. Rivosecchi, L. Lancella, F. Ticca, V. Vullo, S. Delia. 1994. Cerebrospinal fluid interleukin 8 in children with purulent bacterial and tuberculous meningitis. Pediatr. Infect. Dis. J. 13:1008.[Medline]
  25. Halstensen, A., M. Ceska, P. Brandtzaeg, H. Redl, A. Naess, A. Waage. 1993. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167:471.[Medline]
  26. Van Meir, E., M. Ceska, F. Effenberger, A. Walz, E. Grouzmann, I. Desbaillets, K. Frei, A. Fontana, N. de Tribolet. 1992. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res. 52:4297.[Abstract/Free Full Text]
  27. stergaard, Ø, T. L. C., F. Benfield, G. Sellebjerg, N. Kronberg, N. Lohse, J. D. Lundgren. 1996. Interleukin-8 in cerebrospinal fluid from patients with septic and aseptic meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 15:166.[Medline]
  28. Yoshimura, T., K. Matsushima, J. J. Oppenheim, E. J. Leonard. 1987. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin-1 (IL-1). J. Immunol. 139:788.[Abstract]
  29. Baggiolini, M., B. Moser, I. Clark-Lewis. 1994. Interleukin-8 and related chemotactic cytokines: the Giles Filley lecture. Chest 105:95S.
  30. Harada, A., N. Mukaida, K. Matsushima. 1996. Interleukin-8 as a novel target for intervention therapy in acute inflammatory diseases. Mol. Med. Today 2:482.[Medline]
  31. Huber, A. R., S. L. Kunkel, III R. F. Todd, S. J. Weiss. 1991. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99.[Abstract/Free Full Text]
  32. Aloisi, F., A. Caré, G. Borsellino, P. Gallo, S. Rosa, A. Bassani, A. Cabibbo, U. Testa, G. Levi, C. Peschle. 1992. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1ß and tumor necrosis factor-{alpha}. J. Immunol. 149:2358.[Abstract]
  33. del Rio-Hortega, P.. 1932. Microglia. W. Penfield, ed. In Cytology and Cellular Pathology of the Nervous System Vol. 2:481. Hocker, New York.
  34. Chao, C. C., S. Hu, K. Close, C. S. Choi, T. W. Molitor, W. J. Novick, P. K. Peterson. 1992. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 166:847.[Medline]
  35. Chao, C. C., S. Hu, M. Tsang, T. W. Molitor, W. R. Anderson, P. K. Peterson. 1992. Effects of transforming growth factor-ß on murine astrocyte glutamine synthetase activity: implications in neuronal injury. J. Clin. Invest. 90:1786.
  36. Chomczynski, P., N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.[Medline]
  37. Adams, D. H., A. R. Lloyd. 1997. Chemokines: leukocyte recruitment and activation cytokines. Lancet 349:490.[Medline]
  38. Glabinski, A. R., M. Tani, S. Aras, M. H. Stoler, V. K. Tuohy, R. M. Ransohoff. 1995. Regulation and function of central nervous system chemokines. Int. J. Dev. Neurosci. 13:153.[Medline]
  39. Meda, L., C. Bonaiuto, G. I. Szendrei, M. Ceska, F. Rossi, M. A. Cassatella. 1995. ß-Amyloid (25–35) induces the production of interleukin-8 from human monocytes. J. Neuroimmunol. 59:29.[Medline]
  40. Gitter, B. D., L. M. Cox, R. E. Rydel, P. C. May. 1995. Amyloid ß peptide potentiates cytokine secretion by interleukin-1ß-activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA 92:10738.[Abstract/Free Full Text]
  41. Taub, D. D., J. J. Oppenheim. 1994. Chemokines, inflammation and the immune system. Ther. Immunol. 1:229.[Medline]
  42. Harada, A., N. Sekido, T. Akahoshi, T. Wada, M. Mukaida, K. Matsushima. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukocyte Biol. 56:559.[Abstract]
  43. Bell, M. D., D. D. Taub, V. H. Perry. 1996. Overriding the brain’s intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant cytokines. Neuroscience 74:283.[Medline]
  44. Andersson, P. B., V. H. Perry, S. Gordon. 1992. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J. Exp. Med. 176:255.[Abstract/Free Full Text]
  45. Taub, D. D., M. Anver, J. J. Oppenheim, D. L. Longo, W. J. Murphy. 1996. T lymphocyte recruitment by interleukin-8 (IL-8): IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J. Clin. Invest. 97:1931.[Medline]
  46. Metzner, B., M. Marbisch, F. Parlow, E. Kownatzki, I. Schraufstatter, J. Norgauer. 1995. Interleukin-8 and GRO alpha prime human neutrophils for superoxide anion production and induce up-regulation of N-formyl peptide receptors. J. Investig. Dermatol. 104:789.[Medline]
  47. Smith, W. B., L. Noack, Y. Khew-Goodall, S. Isenmann, M. A. Vadas, J. R. Gamble. 1996. Transforming growth factor-ß1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J. Immunol. 157:360.[Abstract]
  48. Chen, C. C., A. M. Manning. 1996. TGF-beta 1, IL-10, and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 8:58.[Medline]
  49. Cassatella, M. A., L. Meda, S. Bonora, M. Ceska, G. Constantin. 1993. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207.[Abstract/Free Full Text]
  50. Koedel, U., A. Bernatowicz, K. Frei, A. Fontana, H. W. Pfister. 1996. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157:5185.[Abstract]
  51. Van Furth, A. M., E. M. Seijmonbergen, J. A. Langermans, P. H. Groeneveld, C. E. de Bel, R. van Furth. 1995. High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin. Infect. Dis. 21:220.[Medline]
  52. Kornelisse, R. F., H. F. Savelkoul, P. H. Mulder, M. H. Suur, P. J. va der Straaten, A. J. van der Heijden, R. N. Sukhai, H. Hahlen, H. J. Neijens, R. de Groot. 1996. Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis. J. Infect. Dis. 173:1498.[Medline]
  53. Ossege, L. M., B. Voss, T. Wiethege, E. Sindern, and J. P. Malin. Detection of transforming growth factor beta 1 mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization. J. Neurol. 242:14.
  54. Ott, L., C. J. McClain, M. Gillespie, B. Young. 1994. Cytokines and metabolic dysfunction after severe head injury. J. Neurotrauma 11:447.[Medline]
  55. Carlos, T. M., R. S. B. Clark, D. Franicola-Higgins, J. K. Schiding, P. M. Kochanek. 1997. Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J. Leukocyte Biol. 61:279.[Abstract]



This article has been cited by other articles:


Home page
NeurologyHome page
R. M. Mitchell, W. M. Freeman, W. T. Randazzo, H. E. Stephens, J. L. Beard, Z. Simmons, and J. R. Connor
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis
Neurology, January 6, 2009; 72(1): 14 - 19.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. Goczalik, E. Ulbricht, M. Hollborn, M. Raap, S. Uhlmann, M. Weick, T. Pannicke, P. Wiedemann, A. Bringmann, A. Reichenbach, et al.
Expression of CXCL8, CXCR1, and CXCR2 in Neurons and Glial Cells of the Human and Rabbit Retina
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4578 - 4589.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Sekine, Y. Ouchi, G. Sugihara, N. Takei, E. Yoshikawa, K. Nakamura, Y. Iwata, K. J. Tsuchiya, S. Suda, K. Suzuki, et al.
Methamphetamine Causes Microglial Activation in the Brains of Human Abusers
J. Neurosci., May 28, 2008; 28(22): 5756 - 5761.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. J. G. Zwijnenburg, T. van der Poll, J. J. Roord, and A. M. van Furth
Chemotactic Factors in Cerebrospinal Fluid during Bacterial Meningitis
Infect. Immun., March 1, 2006; 74(3): 1445 - 1451.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W. S. Sheng, S. Hu, H. T. Ni, T. N. Rowen, J. R. Lokensgard, and P. K. Peterson
TNF-{alpha}-induced chemokine production and apoptosis in human neural precursor cells
J. Leukoc. Biol., December 1, 2005; 78(6): 1233 - 1241.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Saeed, S. Varma, T. Peng, K. J. Tracey, B. Sherry, and C. N. Metz
Ethanol Blocks Leukocyte Recruitment and Endothelial Cell Activation In Vivo and In Vitro
J. Immunol., November 15, 2004; 173(10): 6376 - 6383.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson
Role of Microglia in Central Nervous System Infections
Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. C.-J. Cheeran, S. Hu, W. S. Sheng, P. K. Peterson, and J. R. Lokensgard
CXCL10 Production from Cytomegalovirus-Stimulated Microglia Is Regulated by both Human and Viral Interleukin-10
J. Virol., April 15, 2003; 77(8): 4502 - 4515.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
P. Mendez-Samperio, E. Garcia, A. Vazquez, and J. Palma
Regulation of Interleukin-8 by Interleukin-10 and Transforming Growth Factor {beta} in Human Monocytes Infected with Mycobacterium bovis
Clin. Vaccine Immunol., July 1, 2002; 9(4): 802 - 807.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Gelati, E. Corsini, M. De Rossi, L. Masini, G. Bernardi, G. Massa, A. Boiardi, and A. Salmaggi
Methylprednisolone Acts on Peripheral Blood Mononuclear Cells and Endothelium in Inhibiting Migration Phenomena in Patients With Multiple Sclerosis
Arch Neurol, May 1, 2002; 59(5): 774 - 780.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. K. Coombes and J. B. Mahony
cDNA Array Analysis of Altered Gene Expression in Human Endothelial Cells in Response to Chlamydia pneumoniae Infection
Infect. Immun., March 1, 2001; 69(3): 1420 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
H. Zhang, S. Wei, J. Sun, D. Coppola, B. Zhong, G. D. Wu, B. Goodwin, S. Sebti, J. Y. Djeu, and G. Blanck
Retinoblastoma Protein Activation of Interleukin 8 Expression Inhibits Tumor Cell Survival in Nude Mice
Cell Growth Differ., December 1, 2000; 11(12): 635 - 639.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
T. Jinquan, C. Jing, H. H. Jacobi, C. M. Reimert, A. Millner, S. Quan, J. B. Hansen, S. Dissing, H.-J. Malling, P. S. Skov, et al.
CXCR3 Expression and Activation of Eosinophils: Role of IFN-{gamma}-Inducible Protein-10 and Monokine Induced by IFN-{gamma}
J. Immunol., August 1, 2000; 165(3): 1548 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
A. SINGH, R. KULSHRESHTHA, and A. MATHUR
Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection
J. Med. Microbiol., July 1, 2000; 49(7): 607 - 612.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Hu, H. Ali, W. S. Sheng, L. C. Ehrlich, P. K. Peterson, and C. C. Chao
Gp-41-Mediated Astrocyte Inducible Nitric Oxide Synthase mRNA Expression: Involvement of Interleukin-1beta Production by Microglia
J. Neurosci., August 1, 1999; 19(15): 6468 - 6474.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Ostergaard, T. Benfield, B. Gesser, A. Kharazmi, N. Frimodt-Moller, F. Espersen, and J. D. Lundgren
Pretreatment with Granulocyte Colony-Stimulating Factor Attenuates the Inflammatory Response but Not the Bacterial Load in Cerebrospinal Fluid during Experimental Pneumococcal Meningitis in Rabbits
Infect. Immun., July 1, 1999; 67(7): 3430 - 3436.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Saas, J. Boucraut, A.-L. Quiquerez, V. Schnuriger, G. Perrin, S. Desplat-Jego, D. Bernard, P. R. Walker, and P.-Y. Dietrich
CD95 (Fas/Apo-1) as a Receptor Governing Astrocyte Apoptotic or Inflammatory Responses: A Key Role in Brain Inflammation?
J. Immunol., February 15, 1999; 162(4): 2326 - 2333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Janabi, I. Hau, and M. Tardieu
Negative Feedback Between Prostaglandin and {alpha}- and {beta}-Chemokine Synthesis in Human Microglial Cells and Astrocytes
J. Immunol., February 1, 1999; 162(3): 1701 - 1706.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehrlich, L. C.
Right arrow Articles by Chao, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehrlich, L. C.
Right arrow Articles by Chao, C. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS